Home StocksGLPL

GLPL Share Price

₹ 43.20

-1.69 (-3.76%)

as on 25 Jun 2026 at 15:29

BSE

Market Cap₹41 Cr

PE Ratio0.00

ROCE38.46%

Goldline Pharmaceutical

GLPL Share Price

₹ 43.20

-1.69 (-3.76%) loss

as on 25 Jun 2026 at 15:29

BSE

Overview

News

History

Fundamentals

Investment Returns

Technicals

Financials

Balance Sheet

Cash Flow

Corporate Actions

Today Goldline Pharmaceutical opened at 44.62 while its previous close was at 44.89. In todays trading session GLPL reached a high of 44.62 and low of 43.20. The average traded price for today is 43.66. The 50 DMA stands at - and 200 DMA is at -. Looking at intraday trend, the stock is in Downtrend.

Get 10+ Layouts, 100+ Indicators, Custom Timeframes & All Drawing Tools for FREE.

Use Chart

GLPL Stock Performance

Markets Today

High

44.62

Low

43.20

Open at

44.62

Prev Close

44.89

Volumes

36,000

Avg Price

43.66

Lower Circuit

34.60

Upper Circuit

51.90

Last Traded Details

Quantity

3,000

Time

15:29:20

Price Movement

43.2044.62

0.00%

down side

up side

3.18%

Historical Performance

3 M High

60.00

3 M Low

41.41

1 Yr High

60.00

1 Yr Low

41.41

3 Yr High

60.00

3 Yr Low

41.41

5 Yr High

60.00

5 Yr Low

41.41

1-Year Performance

41.4160.00

4.32%

down side

up side

28.00%

View In-Depth

Get forecast for Price, ROA & ROE based on analyst ratings.

Get Forecast

GLPL Latest News

View All

GLPL Share Price History

View In-Depth

GLPL Fundamentals

Company Valuation

Market Cap (₹ Cr.)

PE Ratio

PB Ratio

2.14

Dividend Yield

ROE

27.37%

ROCE

38.46%

Book Value (₹)

21.00

Face Value (₹)

10.00

Analyse GLPL with 12+ custom fundamentals and financial ratios.

Analyse Now

Share Holding Pattern

Held By	Sep 2025	May 2026
Promoters	79.71%	79.71%
Domestic Institutional Investors (DII)	0.00%	0.00%
Foreign Institutional Investors (FII)	0.00%	0.00%
Public Investors	0.00%	0.00%
Government	0.00%	0.00%

May 2026
Sep 2025

Promoters

79.71%

Domestic Institutional Investors (DII)

0.00%

Foreign Institutional Investors (FII)

0.00%

Public Investors

0.00%

Government

0.00%

View In-Depth

Goldline Pharmaceutical Return Calculator

You have invested

Investment Period

Current value of ₹1,00,000 invested 1 year ago, as on today

₹ 0

Loss

₹ 1,00,000 (23.9%)

Invest Now

Note: Past profits do not guarantee future returns.

GLPL Investment Returns

Short Term

1 Week

0.35%

1 Month

-11.28%

3 Months

-23.9%

6 Months

-23.9%

9 Months

-23.9%

Long Term

1 Year

-23.9%

2 Years

-23.9%

3 Years

-23.9%

4 Years

-23.9%

5 Years

-23.9%

In Short Term
In Long term

1 Week

0.35%

1 Month

-11.28%

3 Months

-23.9%

6 Months

-23.9%

9 Months

-23.9%

View In-Depth

Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.

Start SIP

GLPL Technicals

Moving Averages

Classic

Exponential

Period	Simple	Signal
5-SMA	44.24	Bullish
10-SMA	44.79	Bullish
20-SMA	45.00	Bearish
50-SMA	0.00	Bullish
100-SMA	0.00	Bullish
200-SMA	0.00	Bullish

Technical Indicators

Indicator	Value	Action
RSI(14)	39.39	Neutral
ATR(14)	3.06	Less Volatile
STOCH(9,6)	29.24	Neutral
STOCH RSI(14)	0.00	Oversold
MACD(12,26)	0.00	Bearish
ADX(14)	0.00	Weak Trend

Summary of Technical Indicators for GLPL

View In-Depth

Margin on GLPL

Order Type	Margin to Pay	Leverage	Quantity	Trade Value	Margin Amount	Actions

*Calculated on NSE. Applicable on all exchanges. Margins are subject to change from time to time or may be withdrawn under volatile market conditions. Intraday Orders are square-off automatically at 03:19 pm on NSE / BSE or on hitting 80% of margin utilisation (whichever earlier).

GLPL Financials Summary

Sorry, No Data Available at this Moment!

GLPL Financials

Income Statement

In Cr

Sorry, No Data Available at this Moment!

Balance Sheet

In Cr

Sorry, No Data Available at this Moment!

Cash Flow

In Cr

Sorry, No Data Available at this Moment!

View In-Depth

Corporate Actions

Date	Corporate Action	Information
9th Jun 2026, Tuesday	Stock Result	Q4 FY 26-27 Results

The above dates are ex-dates.

View All

Check GLPL latest Company Filings, Investor Presentation & Conference Call details.

Read Now

GLPL Revenue Growth

All values are in Crores

Revenue

Profit

Loss

Financial Year	Revenue	Revenue Growth	Net Profit	Profit Growth
FY 2024-25	31	19.05%	4	56.93%
FY 2023-24	28	18.73%	3	603.82%
FY 2022-23	24	%	2	1000.35%

Top Mutual Funds Invested in GLPL

Name	NAV	AUM	Weightage	1Y Return	3Y Return	5Y Return	Expense Ratio

Open IPOs

View All IPOs

Calculators

Brokerage Calculator

Margin Calculator

MTF Calculator

Stock Return Calculator

Stock Average Calculator

View All

What's New In The Market

View All

FAQs on GLPL

What is the share price of Goldline Pharmaceutical?

Goldline Pharmaceutical share price as of today is ₹ 43.20 as on 25 Jun 2026 at 15:29.

What is the 52W high and 52W low of Goldline Pharmaceutical?

The 52W high of Goldline Pharmaceutical is ₹ 60.00 and 52W low is ₹ 41.41 as of 25 Jun 2026 at 15:29.

What is the return on Goldline Pharmaceutical share?

The past returns of Goldline Pharmaceutical share are -

Past 1 year: -23.90%
Past 3 years: -23.90%
Past 5 years: -23.90%

What is the PE and PB Ratio of Goldline Pharmaceutical?

The PE and PB ratio of Goldline Pharmaceutical stands at 0.00 and 2.14 respectively as on 25 Jun 2026 at 15:29.

What is the EPS of Goldline Pharmaceutical?

The EPS of Goldline Pharmaceutical is 0.00 for the quarter ended 0.00 and 0.00 for the financial year 0.00.

What is the shareholding pattern of Goldline Pharmaceutical?

The shareholding pattern of Goldline Pharmaceutical is as follows:

DIIs - 0.00%
FII - 0.00%
Promoters - 79.71%
Public Investors 0.00%
Goverenment - 0.00%

How to buy Goldline Pharmaceutical shares online?

Yes, you can buy shares of Goldline Pharmaceutical online by opening Demat account with Dhan.

How to buy Goldline Pharmaceutical shares on Dhan?

If you are a Dhan user already, you can buy Goldline Pharmaceutical stocks from Dhan Trading App or Web Trading Platform. If you are new to Dhan follow the below steps:

Download the Dhan App to Open a Demat Account
Navigate to the “Money Tab”
Add money to your account
Search for Goldline Pharmaceutical share
Tap on “Buy”

With Dhan you can start a daily, weekly or monthly SIP in Goldline Pharmaceutical.

How to buy Goldline Pharmaceutical shares after market is closed?

You can easily buy the shares of Goldline Pharmaceutical even after the markets are closed using the After Market Order feature on Dhan Trading App.

Explore | Sitemap

*All securities mentioned on this website are exemplary and not recommendatory.

*Current prices on the website are delayed by 15 mins, login to check live prices.

We are bullish on India, we are bullish on India's prospects to be one of the largest economies in the world. We believe that the stock market provides a unique opportunity for all of India's traders and investors to participate in the growth story of the country.

Yet, most investing & trading platforms in India have remained more or less the same over the past decade. Times have changed and retail traders and investors have become smarter about managing their trades and money. Modern traders & investors require an online trading platform that helps them keep up with the technological advancements of our time.

That's why we're building Dhan - to help you trade, to help you invest, and to help you participate in India's growth stock via the stock market with awesome features and an incredible experience.

We are doing so by giving you access to not just one but 6 products within the Dhan ecosystem:

Dhan App: The only online trading app you need for buying and selling equity, futures, options, commodity, and currency.
Dhan Web: Trade on the big screen across segments with our web trading platform.
Options Trader App: A dedicated option trading app built for India's F&O traders.
Options Trader Web: Love big screens and F&O trading? Use our web option trading platform.
Dhan + TradingView: The magic of Tradingview charts for free with the Lightning-Fast experience of Dhan on tv.dhan.co.
Connect to TradingView: Our Tradingview broker integration allows you to trade in Stocks, Futures, and Commodities directly from tradingview.com via Dhan.

This means that with Dhan, you'll be able to start:

Lakhs of users already trust Dhan for their online stock trading and investing needs. Dhan is growing rapidly because of the love we receive from SuperTraders and Long-Term Investors who acknowledge that the platform is innovating for them, building super useful features that help them do everything from investing in stock market to trading F&O like a pro on the Tradingview charts and much more.

While we are growing, we will always remember why we started building in the first place - you. Our user-first approach will always be at the heart of our philosophy. Come join us on this incredible journey!

Try it out, you can close your account at anytime using this link.

©2021-2026 Raise Securities Private Limited (formerly Moneylicious Securities Private Limited). All rights reserved. CIN: U74999MH2012PTC433549 Raise Securities is part of Raise Financial Services and works closely with Raise Partners across services.

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016 | SEBI Research Analyst Registration No: INH000023357
Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320
Registered & Corporate Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai – 400104, Customer Care: 9987761000.

Details of client bank account

For any query / feedback / clarifications, email at help@dhan.co.

In case of grievances for any of the services rendered by Raise Securities Private Limited, please write to grievance@dhan.co (for NSE, BSE and MCX) or grievancedp@dhan.co (for Depository Participant). Please ensure that you carefully read the Risk Disclosure Document as prescribed by SEBI, our Terms of Use and Privacy Policy. Compliance Officer: Mr. Manish Garg and Mobile: 8655740961 Email: complianceofficer@dhan.co To lodge your complaints using SEBI SCORES, click here.

Disclaimer: All communications with the client via chat, phone, or email are for support purposes only. Any commitments or statements made by the agent (human or virtual) shall not be binding on the company.

DHAN is a brand owned by Raise Securities Private Limited. All DHAN clients are registered under Raise Securities Private Limited. Clients are advised to refer to our company as Raise Securities Private Limited when communicating with regulatory authorities.

Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances. You may refer the website https://scores.sebi.gov.in/ for more information. You may also download the SEBI Scores app to log a complaint Android: https://play.google.com store apps sebiscores iOS: https://apps.apple.com app sebiscores.

Disclaimer: Investment in the securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit

Attention investors:

Stock brokers can accept securities as margins from clients only by way of pledge in the depository system w.e.f September 01, 2020.
Update your e-mail and phone number with your stock broker / depository participant and receive OTP directly from depository on your e-mail and/or mobile number to create pledge.
Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month.

Note: As a policy we do not give stock tips or recommendations and have not authorized anyone to give this on behalf of us. If you know anyone claiming to be a part of Dhan / / Raise or our associate companies or partners and offering such services, please report us on help@dhan.co. Important Information for Investors: To prevent unauthorized transactions in your trading / demat account, do not share your account details, credentials or any personal details with anyone. Keep your mobile number updated with your Stock Broker, Depository Participant and ensure that the same is registered with Stock Exchanges, Depository and KRAs. You will receive alerts and information on your registered mobile number / email for debit and other important transactions in your demat account directly from CDSL / Exchange on the same day. KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Stock Broker, DP, Mutual Fund, etc.), you need not undergo the same process again when you approach another intermediary. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. This is issued in the interest of investors.

Investors should be cautious on unsolicited emails and SMS advising to buy, sell or hold securities and trade only on the basis of informed decision. Investors are advised to invest after conducting appropriate analysis of respective companies and not to blindly follow unfounded rumours, tips etc. Further, you are also requested to share your knowledge or evidence of systemic wrongdoing, potential frauds or unethical behaviour through the anonymous portal facility provided on BSE & NSE website. Issued in the interest of the investors.

Raise Securities Private Limited also known as Dhan is only an order collection platform that collects orders on behalf of clients and places them on BSE StarMF for execution. Client expressly agrees that Dhan is not liable or responsible and does not represent or warrant any damages regarding non- execution of orders or any incorrect execution of orders with regard to the funds chosen by the client or due to, but not being limited to, any link/system failure, delay in transfer of the funds on account of any unforeseen circumstances/issues in the banking system/payment aggregators or any other problems that may result in a delay in crediting the funds into the BSE Star MF's bank account. Raise Securities Private Limited (Dhan) does not engage in proprietary trading on its own account.

Mutual fund investments are subject to market risks, read all scheme related documents carefully before investing. Dhan is not a distributor or agent of any mutual fund. Mutual Funds are not exchange-traded products. Any related disputes will not have access to the Exchange-investor redressal forum or arbitration mechanism. For other disclaimers please refer https://dhan.co/advertisement-disclaimer/

Download client registration documents (Rights & Obligations, Risk Disclosure Document, Do's & Don'ts) in vernacular language: BSE | NSE | MCX

Kindly, read the Advisory Guidelines of BSE | NSE | MCX for investors as prescribed by the exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client's assets